pf-06650833
Showing 1 - 11 of 11
Healthy Trial in South Miami (PF-06650833, Ethinyl estradiol (EE) and levonogestrel (LN))
Completed
- Healthy
- PF-06650833
- Ethinyl estradiol (EE) and levonogestrel (LN)
-
South Miami, FloridaQps-Mra, Llc
Jan 5, 2022
COVID-19 Pneumonia Trial in Bronx (PF-06650833, Matching Placebo)
Recruiting
- COVID-19 Pneumonia
- PF-06650833
- Matching Placebo
-
Bronx, New YorkBronx-Lebanon Hospital Center Health Care System
Jun 17, 2021
COVID-19 Trial in New Haven (PF-06650833, Placebo)
Terminated
- COVID-19
- PF-06650833
- Placebo
-
New Haven, ConnecticutYale New Haven Hospital
Oct 18, 2021
Acne Inversa Trial in Australia, Canada, United States (PF-06650833, PF-06700841, PF-06826647)
Completed
- Acne Inversa
- PF-06650833
- +3 more
-
Birmingham, Alabama
- +76 more
Jul 10, 2022
Rheumatoid Arthritis Trial in Worldwide (PF-06650833, PF-06651600, Tofacitinib)
Completed
- Rheumatoid Arthritis
- PF-06650833
- +2 more
-
Pleven, Bulgaria
- +143 more
Mar 2, 2022
Healthy Trial in Brussels (PF-06650833)
Completed
- Healthy
- PF-06650833
-
Brussels, BelgiumPfizer Clinical Research Unit
Apr 17, 2019
Rheumatoid Arthritis Trial in Worldwide (PF-06650833, Placebo, Tofacitinib)
Completed
- Rheumatoid Arthritis
- PF-06650833
- +2 more
-
Tuscaloosa, Alabama
- +102 more
Feb 12, 2020
Healthy Trial in Hachioji-shi (PF-06650833, )
Completed
- Healthy
- PF-06650833
- placebo
-
Hachioji-shi, Tokyo, JapanP-one Clinic, Keikokai Medical Corporation
Oct 3, 2018
Healthy Trial in New Haven (PF-06650833, Placebo)
Completed
- Healthy
- PF-06650833
- Placebo
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Apr 17, 2018
Healthy Trial in New Haven (PF-06650833)
Completed
- Healthy
- PF-06650833
-
New Haven, ConnecticutNew Haven Clinical Research Unit
May 6, 2016
Healthy Trial in New Haven (PF-06650833, Placebo)
Completed
- Healthy
- PF-06650833
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jul 1, 2015